Show simple item record

dc.contributor.authorWorld Health Organizationen_US
dc.coverage.spatialGenevaen_US
dc.date.accessioned2018-04-05T09:28:09Z
dc.date.available2018-04-05T09:28:09Z
dc.date.issued2018
dc.identifier.govdocWHO/CDS/HIV/18.6
dc.identifier.urihttp://www.who.int/iris/handle/10665/272291
dc.description3 p.en_US
dc.language.isoenen_US
dc.publisherWorld Health Organizationen_US
dc.rightsCC BY-NC-SA 3.0 IGOen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0/igoen_US
dc.subject.meshAnti-Retroviral Agentsen_US
dc.subject.meshDrug Utilizationen_US
dc.subject.meshMeeting Abstractsen_US
dc.titleThird conference on antiretroviral drug optimization (‎CADO 3)‎: summary meeting report, 29 Nov-1 Dec 2017, Rosebank Crowne Plaza, Johannesburg, South Africaen_US
dc.typeTechnical documentsen_US
dc.rights.holderWorld Health Organizationen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record